Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jonas, Wastesson"'
Autor:
Juan Manuel Pinar Manzanet, Giuseppe Fico, Beatriz Merino‐Barbancho, Liss Hernández, Cecilia Vera‐Muñoz, Germán Seara, Macarena Torrego, Henar Gonzalez, Jonas Wastesson, Johan Fastbom, Julio Mayol, Kristina Johnell, Tomás Gómez‐Gascón, María Teresa Arredondo
Publikováno v:
Healthcare Technology Letters, Vol 10, Iss 3, Pp 62-72 (2023)
Abstract Age‐related changes in pharmacokinetics and pharmacodynamics, multimorbidity, frailty, and cognitive impairment represent challenges for drug treatments. Moreover, older adults are commonly exposed to polypharmacy, leading to increased ris
Externí odkaz:
https://doaj.org/article/6ba91e9cfd3b40d79438f2f6784d0908
Autor:
Francesca Eroli, Christina Tsagkogianni, Stefania Zerial, Felix Andersson, Zeynep Acararicin, Maria Latorre-Leal, Jonas Wastesson, Angel Cedazo-Minguez, Kristina Johnell, Silvia Maioli
Publikováno v:
Cerebral Circulation - Cognition and Behavior, Vol 6, Iss , Pp 100309- (2024)
Objectives: Cardiovascular conditions like hypercholesterolemia and hypertension increase the risk for Alzheimer's Disease (AD). Thus, certain AD risk profiles may benefit from optimized multi- medication therapies including for example cholesterol-l
Externí odkaz:
https://doaj.org/article/3a924c5836b3426ea6ee9dea1e64fe98
Autor:
Francesca, Eroli, Kristina, Johnell, María, Latorre-Leal, Sarah, Hilmer, Jonas, Wastesson, Angel, Cedazo-Minguez, Maioli, Silvia
Publikováno v:
Aging (Albany NY)
The potential harmful effects of polypharmacy (concurrent use of 5 or more drugs) are difficult to investigate in an experimental design in humans. Moreover, there is a lack of knowledge on sex-specific differences on the outcomes of multiple-drug us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::47ea048601a0bdf5e7a85c74acc836d1
http://europepmc.org/articles/PMC8221308
http://europepmc.org/articles/PMC8221308
Autor:
Eroli F; Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Solna, Sweden., Johnell K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Latorre-Leal; Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Solna, Sweden., Hilmer S; Kolling Institute, Royal North Shore Hospital and University of Sydney, Sydney, Australia., Wastesson; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.; Aging Research Center, Karolinska Institutet and Stockholm University, Stockholm, Sweden., Cedazo-Minguez A; Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Solna, Sweden., Maioli S; Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, Center for Alzheimer Research, Division of Neurogeriatrics, Solna, Sweden.
Publikováno v:
Aging [Aging (Albany NY)] 2021 Jun 02; Vol. 13 (11), pp. 14729-14744. Date of Electronic Publication: 2021 Jun 02.